Artificial Intelligence (AI)-Based Personalized Exercise Coaching for Patients With Breast Cancer
NCT07844941
Summary
This prospective, single-center, randomized controlled trial aims to evaluate the effectiveness and safety of an artificial intelligence (AI)-based personalized exercise coaching system in female breast cancer survivors who have completed major cancer treatment and are clinically stable. A total of 100 eligible participants will be randomly assigned in a 1:1 ratio to either an AI-based exercise coaching group or a conventional exercise guidance group. Participants in the intervention group will receive personalized exercise recommendations generated by the AI exercise coaching system, with exercise data collected and used for dynamic adjustment of exercise guidance. Participants in the control group will receive conventional exercise recommendations provided by healthcare professionals. The intervention will last for 6 months. Exercise adherence will be evaluated as the primary outcome. Secondary outcomes will include quality of life, psychological status, physical function, exercise-related adverse events, and laboratory and metabolic parameters.
Eligibility
Inclusion Criteria: 1. Provision of written and dated informed consent. 2. Female participants aged 18 to 70 years. 3. Pathologically confirmed breast malignancy. 4. Completion of major cancer treatment, including surgery, chemotherapy, and/or radiotherapy, with clinically stable disease. 5. No severe cardiopulmonary dysfunction or contraindications to exercise. Exclusion Criteria: 1. Have not undergone breast cancer surgery. 2. Mental or psychological condition, as judged by the investigator, that would prevent adherence to the intervention or completion of follow-up.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07844941